Amlogenyx Inc.

About Amlogenyx Inc.

Amlogenyx is dedicated to developing a novel gene therapy strategy to reduce amyloid accumulation in the brain, aiming to prevent and treat diseases like Alzheimer's disease.

Products & Services

Gene Therapy for Alzheimer's Disease:A novel gene therapy using AAV to deliver supplemental lysosomal protease PPCA to the brain, reducing amyloid plaque accumulation in neurons more effectively than monoclonal antibodies.

Specialties

Gene Therapy Alzheimer's Disease Treatment Lysosomal Dysfunction Amyloid Accumulation Reduction

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 14000000 MR: - FA: USD 14 million FAN: 14000000	D: 2024-08-02 FD: 2024-08-02	2 investors

Seed Latest

2024-08-02

$14.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Alessandra d'Azzo

Emerita Faculty

J

John R. Pinion

Chief Operations Officer

A

Arjun Natesan

Lead Early Research and Development

V

Vimal Srivastava

Lead Business Operations

J

James Warren

Lead Engineering and Manufacturing

E

Emil D. Kakkis, M.D., Ph.D.

Founder and Chairman

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

Amlogenyx Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised